Your browser doesn't support javascript.
Tackling COVID-19 Using Remdesivir and Favipiravir as Therapeutic Options.
Sreekanth Reddy, Obireddy; Lai, Wing-Fu.
  • Sreekanth Reddy O; Department of Chemistry, Sri Sri Krishnadevaraya University, Anantapur, 515003, India.
  • Lai WF; Ciechanover Institute of Precision and Regenerative Medicine, School of Life and Health Sciences, The Chinese University of Hong Kong (Shenzhen), Shenzhen, 518172, P. R. China.
Chembiochem ; 22(6): 939-948, 2021 03 16.
Article in English | MEDLINE | ID: covidwho-935019
ABSTRACT
The human world is currently influenced largely by the outbreak of pandemic COVID-19. At this moment, most researchers focus on developing treatment strategies and measures to work against COVID-19. Treatment strategies specific for COVID-19 are lacking. This article provides an overview of the life cycle and routes of transmission of SARS-CoV-2. The therapeutic effects of two drugs [i. e., remdesivir (RDV) and favipiravir (FPV)] which can potentially tackle COVID-19 are discussed based on current published data. This review can serve as a reference for future studies.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pyrazines / Adenosine Monophosphate / Alanine / Amides / SARS-CoV-2 / COVID-19 Drug Treatment Limits: Animals / Humans Language: English Journal: Chembiochem Journal subject: Biochemistry Year: 2021 Document Type: Article Affiliation country: Cbic.202000595

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pyrazines / Adenosine Monophosphate / Alanine / Amides / SARS-CoV-2 / COVID-19 Drug Treatment Limits: Animals / Humans Language: English Journal: Chembiochem Journal subject: Biochemistry Year: 2021 Document Type: Article Affiliation country: Cbic.202000595